drugset / Trial / NCT00960882
Gastric Tolerability and Pharmacokinetics of DMMET-01
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the gastric tolerability and the pharmacokinetics of a new drug for the treatment of type 2 diabetes, DMMET-01, in healthy volunteers.
Timeline
- Start
- 2007-06
- Primary completion
- 2008-03
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin glycinate | Unknown | 1050.6 mg | — |
Indications
No indication recorded.